FDA approves first COVID-19 drug: antiviral remdesivir

U.S. regulators on Thursday approved the first drug to treat COVID-19: remdesivir, an antiviral medicine given to hospitalized patients through an IV. The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by […]

The post FDA approves first COVID-19 drug: antiviral remdesivir appeared first on Albert Lea Tribune.

You May Also Like

Leave a Reply

Your email address will not be published. Required fields are marked *